Questions and Solutions for the Growing Demand for Clinical Services
Questions and Solutions for the Growing Demand for Clinical Services
David Pope, PharmD, CDE, chief innovation officer for OmniSYS, and John King, CEO of OmniSYS, discuss questions pharmacists have and some solutions to the growing demand for clinical services in pharmacy. This video was filmed at the 2019 NACDS Total Store Expo in Boston.
Learn More about Clinical Roles
Latest News

The Oncology Pharmacist's Blind Spot
Hematology and oncology pharmacists discussed patient outreach at a panel during the Hematology/Oncology Pharmacy Association’s (HOPA) annual conference in April.
The Importance of Financial Counseling Services for Patients With Cancer
As the cost of treating the disease has risen, so too have the direct medical care expenses that patients pay out of pocket, as commercial insurers increasingly shift the burden of paying for treatment to patients through higher premiums, deductibles, and co-pays.
The Oncology Drug Pathway: Getting Medications From the Pharmacy to the Patient
Despite advances in cancer care, patients typically face obstacles to treatment.
Medical Marijuana in Community Oncology
During a presentation at the recent Community Oncology Alliance Annual Conference in Orlando, Florida, Ray Bailey, RPh, discussed the implications of medical marijuana for patients with cancer.
Lessons Learned: Starting a Health-System, Oncology-focused Specialty Pharmacy
Health-system–owned and operated specialty pharmacies have become a trend to not only capture previously unrealized profit but to also close the gap between provider, patient, and medication.
Methylnaltrexone May Be A Solution to Opioid-Induced Constipation
Researchers have found that methylnaltrexone, a peripherally acting µ-opioid receptor antagonist, may offer an effective solution to relieving patients' opioid-induced constipation with minimal adverse effects.
FDA OKs Pembrolizumab/Lenvatinib Combo for Advanced Endometrial Carcinoma
The FDA approval of pembrolizumab plus lenvatinib for this new indication is the first under a new international collaboration with Australia and Canada.
Ofatumumab Demonstrates Efficacy in Relapsing Multiple Sclerosis
Two phase 3 studies showed that ofatumumab was superior to teriflunomide (Aubagio) in patients with relapsing forms of multiple sclerosis.
New Direction in Chronic Inflammation Treatment Development
Research demonstrates a new direction in cell signaling and treatment for chronic inflammatory diseases such as psoriasis, asthma, and HIV. 
NASP 2019: A Doctor's Perspective on Specialty Pharmacy
The annual National Association of Specialty Pharmacy annual meeting shed light on the significant role these caregivers play in patient care.
How Clinic-Based Specialty Pharmacy Services Strengthen Health Systems of Every Size
The significant jump in hospital-owned specialty pharmacies bolsters the belief that health system leaders increasingly understand how these services enable their organizations to enhance patient care and achieve market differentiation.
Purdue Pharma Seeks Bankruptcy Protection, Settlement of Opioid-Related Cases
The parties included in this agreement in principle represent some of the more than 2,600 lawsuits filed against Purdue Pharma concerning opioids, including the company’s OxyContin products.
+ Load More

Explore More About Pharmacy Times